The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis
Open accessAbstract
Toxoplasma gondii is known to infect a considerable number of mammalian and avian species and a substantial proportion of the world’s human population. The parasite has an impressive ability to disseminate within the host’s body and employs various tactics to overcome the highly regulatory blood-brain barrier and reside in the brain. In healthy individuals,T. gondii infection is largely tolerated without any obvious ill effects. However, primary infection in immunosuppressed patients can result in acute cerebral or systemic disease, and reactivation of latent tissue cysts can lead to a deadly outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Toxoplasma gondii: from animals to humans
Tenter, A. M., Heckeroth, A. R., & Weiss, L. M. (2000) · International Journal for Parasitology · doi:10.1016/s0020-7519(00)00124-7 · Cited by 3,702
Montoya, J., & Liesenfeld, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16412-x · Cited by 3,232
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
Robert-Gangneux, F., & Dardé, M.-L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05013-11 · Cited by 1,815
Kaplan, J. E., Benson, C., Holmes, K. K., Brooks, J. T., Pau, A., & Masur, H. (2009) · PsycEXTRA Dataset · doi:10.1037/e537722009-001 · Cited by 1,343
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269
Dubey, J. P., Lindsay, D. S., & Speer, C. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.267 · Cited by 1,181
TLR11 Activation of Dendritic Cells by a Protozoan Profilin-Like Protein
Yarovinsky, F., Zhang, D., Andersen, J. F., Bannenberg, G. L., Serhan, C. N., Hayden, M. S., Hieny, S., Sutterwala, F. S., Flavell, R. A., Ghosh, S., et al. (2005) · Science · doi:10.1126/science.1109893 · Cited by 1,048
Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V., Huang, Q., Yoshimura, A., Sehy, D., et al. (2006) · Nature Immunology · doi:10.1038/ni1376 · Cited by 955
Gazzinelli, R. T., Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Kühn, R., Müller, W., Trinchieri, G., & Sher, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.798 · Cited by 927
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Dorlo, T. P. C., Balasegaram, M., Beijnen, J. H., & de Vries, P. J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks275 · Cited by 775
Fatal attraction in rats infected with Toxoplasma gondii
Berdoy, M., Webster, J. P., & Macdonald, D. W. (2000) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2000.1182 · Cited by 734
Toxoplasmic Encephalitis in Patients With Acquired Immune Deficiency Syndrome
Luft, B. J. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350070031018 · Cited by 714
Toxoplasmosis of the Central Nervous System in the Acquired Immunodeficiency Syndrome
Porter, S. B., & Sande, M. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272306 · Cited by 670
Ito, T., Yang, M., Wang, Y.-H., Lande, R., Gregorio, J., Perng, O. A., Qin, X.-F., Liu, Y.-J., & Gilliet, M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061660 · Cited by 643
TH1 cells control themselves by producing interleukin-10
O'Garra, A., & Vieira, P. (2007) · Nature Reviews Immunology · doi:10.1038/nri2097 · Cited by 617
Hoffmann, S., Batz, M. B., & Morris, J. G. (2012) · Journal of Food Protection · doi:10.4315/0362-028x.jfp-11-417 · Cited by 612
Jankovic, D., Kullberg, M. C., Feng, C. G., Goldszmid, R. S., Collazo, C. M., Wilson, M., Wynn, T. A., Kamanaka, M., Flavell, R. A., & Sher, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062175 · Cited by 594
Gazzinelli, R., Xu, Y., Hieny, S., Cheever, A., & Sher, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.1.175 · Cited by 574
Adams, L. B., Hibbs, J. B., Taintor, R. R., & Krahenbuhl, J. L. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.7.2725 · Cited by 563
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice
Dunay, I. R., Gajurel, K., Dhakal, R., Liesenfeld, O., & Montoya, J. G. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00057-17 · Cited by 553
Batz, M. B., Hoffmann, S., & Morris, J. G. (2012) · Journal of Food Protection · doi:10.4315/0362-028x.jfp-11-418 · Cited by 546
Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells
Harris, T. H., Banigan, E. J., Christian, D. A., Konradt, C., Tait Wojno, E. D., Norose, K., Wilson, E. H., John, B., Weninger, W., Luster, A. D., et al. (2012) · Nature · doi:10.1038/nature11098 · Cited by 512
History of the discovery of the life cycle of Toxoplasma gondii
Dubey, J. P. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.01.005 · Cited by 506
Antibodies to Toxoplasma gondii in Patients With Schizophrenia: A Meta-Analysis
Torrey, E. F., Bartko, J. J., Lun, Z.-R., & Yolken, R. H. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl050 · Cited by 503
NAVIA, B. A., Petito, C. K., GOLD, J. W. M., Cho, E., Jordan, B. D., & Price, R. W. (1986) · Annals of Neurology · doi:10.1002/ana.410190303 · Cited by 502
Risk Factors for Toxoplasma gondii Infection in the United States
Jones, J. L., Dargelas, V., Roberts, J., Press, C., Remington, J. S., & Montoya, J. G. (2009) · Clinical Infectious Diseases · doi:10.1086/605433 · Cited by 490
Scanga, C. A., Aliberti, J., Jankovic, D., Tilloy, F., Bennouna, S., Denkers, E. Y., Medzhitov, R., & Sher, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.5997 · Cited by 487
Scharton-Kersten, T. M., Yap, G., Magram, J., & Sher, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1261 · Cited by 433
Jones, J. L., & Dubey, J. P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis508 · Cited by 407
Kiss and spit: the dual roles of Toxoplasma rhoptries
Boothroyd, J. C., & Dubremetz, J.-F. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1800 · Cited by 406
Dannemann, B., McCutchan, J. A., Israelski, D., Antoniskis, D., Leport, C., Luft, B., Nussbaum, J., Clumeck, N., Morlat, P., Chiu, J., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-33 · Cited by 360
Disruption of Toxoplasma gondii Parasitophorous Vacuoles by the Mouse p47-Resistance GTPases
Martens, S., Parvanova, I., Zerrahn, J., Griffiths, G., Schell, G., Reichmann, G., & Howard, J. C. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010024 · Cited by 356
Hall, A. O., Beiting, D. P., Tato, C., John, B., Oldenhove, G., Lombana, C. G., Pritchard, G. H., Silver, J. S., Bouladoux, N., Stumhofer, J. S., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.014 · Cited by 344
Koblansky, A. A., Jankovic, D., Oh, H., Hieny, S., Sungnak, W., Mathur, R., Hayden, M. S., Akira, S., Sher, A., & Ghosh, S. (2013) · Immunity · doi:10.1016/j.immuni.2012.09.016 · Cited by 342
Toxoplasma Effectors Targeting Host Signaling and Transcription
Hakimi, M.-A., Olias, P., & Sibley, L. D. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00005-17 · Cited by 339
Yamamoto, M., Okuyama, M., Ma, J. S., Kimura, T., Kamiyama, N., Saiga, H., Ohshima, J., Sasai, M., Kayama, H., Okamoto, T., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.009 · Cited by 330
Toxoplasma gondii Infection in Immunocompromised Patients: A Systematic Review and Meta-Analysis
Wang, Z.-D., Liu, H.-H., Ma, Z.-X., Ma, H.-Y., Li, Z.-Y., Yang, Z.-B., Zhu, X.-Q., Xu, B., Wei, F., & Liu, Q. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00389 · Cited by 311
Self-citationAnti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent
Machado, F. S., Johndrow, J. E., Esper, L., Dias, A., Bafica, A., Serhan, C. N., & Aliberti, J. (2006) · Nature Medicine · doi:10.1038/nm1355 · Cited by 310
Lambert, H., Hitziger, N., Dellacasa, I., Svensson, M., & Barragan, A. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00735.x · Cited by 287
Wang, Z.-D., Wang, S.-C., Liu, H.-H., Ma, H.-Y., Li, Z.-Y., Wei, F., Zhu, X.-Q., & Liu, Q. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30005-x · Cited by 285
Self-citationKindler, J., Lim, C. K., Weickert, C. S., Boerrigter, D., Galletly, C., Liu, D., Jacobs, K. R., Balzan, R., Bruggemann, J., O’Donnell, M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0401-9 · Cited by 284
Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States
Maldonado, Y. A., Read, J. S., & COMMITTEE ON INFECTIOUS DISEASES (2017) · Pediatrics · doi:10.1542/peds.2016-3860 · Cited by 270
Gold, D. A., Kaplan, A. D., Lis, A., Bett, G. C. L., Rosowski, E. E., Cirelli, K. M., Bougdour, A., Sidik, S. M., Beck, J. R., Lourido, S., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.003 · Cited by 268
The development and biology of bradyzoites of toxoplasma gondii
Weiss, L. (2000) · Frontiers in Bioscience · doi:10.2741/weiss · Cited by 266
Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/Cas9
Sidik, S. M., Hackett, C. G., Tran, F., Westwood, N. J., & Lourido, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100450 · Cited by 265
Burden of encephalitis-associated hospitalizations in the United States, 1998-2010
Vora, N. M., Holman, R. C., Mehal, J. M., Steiner, C. A., Blanton, J., & Sejvar, J. (2014) · Neurology · doi:10.1212/wnl.0000000000000086 · Cited by 264
Identification of a Master Regulator of Differentiation in Toxoplasma
Waldman, B. S., Schwarz, D., Wadsworth, M. H., Saeij, J. P., Shalek, A. K., & Lourido, S. (2020) · Cell · doi:10.1016/j.cell.2019.12.013 · Cited by 263
Etheridge, R. D., Alaganan, A., Tang, K., Lou, H. J., Turk, B. E., & Sibley, L. D. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.04.002 · Cited by 254
Katlama, C., De Wit, S., O'Doherty, E., Van Glabeke, M., Clumeck, N., & European Network for Treatment of AIDS (ENTA) Toxoplasmosis Study Group (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.268 · Cited by 253
Jankovic, D., Kullberg, M. C., Hieny, S., Caspar, P., Collazo, C. M., & Sher, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00278-9 · Cited by 252
Doyle, K. P., Cekanaviciute, E., Mamer, L. E., & Buckwalter, M. S. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-62 · Cited by 250
Toxoplasma gondii tachyzoite–bradyzoite interconversion
Lyons, R. E., McLeod, R., & Roberts, C. W. (2002) · Trends in Parasitology · doi:10.1016/s1471-4922(02)02248-1 · Cited by 234
Congenital toxoplasmosis: Priorities for further health promotion action
Elsheikha, H. M. (2008) · Public Health · doi:10.1016/j.puhe.2007.08.009 · Cited by 233
Self-citationCarr, A., Tindall, B., Brew, B. J., Marriott, D. J., Harkness, J. L., Penny, R., & Cooper, D. A. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-106 · Cited by 232
Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells
Aliberti, J., Valenzuela, J. G., Carruthers, V. B., Hieny, S., Andersen, J., Charest, H., e Sousa, C. R., Fairlamb, A., Ribeiro, J. M., & Sher, A. (2003) · Nature Immunology · doi:10.1038/ni915 · Cited by 230
Antinori, A., Ammassari, A., De Luca, A., Cingolani, A., Murri, R., Scoppettuolo, G., Fortini, M., Tartaglione, T., Larocca, L. M., Zannoni, G., et al. (1997) · Neurology · doi:10.1212/wnl.48.3.687 · Cited by 229
Watts, E., Zhao, Y., Dhara, A., Eller, B., Patwardhan, A., & Sinai, A. P. (2015) · mBio · doi:10.1128/mbio.01155-15 · Cited by 223
Blanchard, N., Gonzalez, F., Schaeffer, M., Joncker, N. T., Cheng, T., Shastri, A. J., Robey, E. A., & Shastri, N. (2008) · Nature Immunology · doi:10.1038/ni.1629 · Cited by 221
Treatment of toxoplasmosis: Current options and future perspectives
Konstantinovic, N., Guegan, H., Stäjner, T., Belaz, S., & Robert-Gangneux, F. (2019) · Food and Waterborne Parasitology · doi:10.1016/j.fawpar.2019.e00036 · Cited by 218
Andrade, W. A., Souza, M. D. C., Ramos-Martinez, E., Nagpal, K., Dutra, M. S., Melo, M. B., Bartholomeu, D. C., Ghosh, S., Golenbock, D. T., & Gazzinelli, R. T. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2012.12.003 · Cited by 216
A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis
Wilson, E. H., Wille-Reece, U., Dzierszinski, F., & Hunter, C. A. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.018 · Cited by 216
Neurons are the Primary Target Cell for the Brain-Tropic Intracellular Parasite Toxoplasma gondii
Cabral, C. M., Tuladhar, S., Dietrich, H. K., Nguyen, E., MacDonald, W. R., Trivedi, T., Devineni, A., & Koshy, A. A. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005447 · Cited by 209
Aliberti, J., Serhan, C., & Sher, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021183 · Cited by 204
Burden of encephalitis-associated hospitalizations in the United States, 1988-1997
Khetsuriani, N., Holman, R. C., & Anderson, L. J. (2002) · Clinical Infectious Diseases · doi:10.1086/341301 · Cited by 200
Murine Guanylate Binding Protein 2 (mGBP2) controls Toxoplasma gondii replication
Degrandi, D., Kravets, E., Konermann, C., Beuter-Gunia, C., Klümpers, V., Lahme, S., Rasch, E., Mausberg, A. K., Beer-Hammer, S., & Pfeffer, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205635110 · Cited by 196
Toxoplasma gondii infection of the central nervous system
Conley, F. K., Jenkins, K. A., & Remington, J. S. (1981) · Human Pathology · doi:10.1016/s0046-8177(81)80170-0 · Cited by 193
Konradt, C., Ueno, N., Christian, D. A., Delong, J. H., Pritchard, G. H., Herz, J., Bzik, D. J., Koshy, A. A., McGavern, D. B., Lodoen, M. B., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.1 · Cited by 193
Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis
Doggett, J. S., Nilsen, A., Forquer, I., Wegmann, K. W., Jones-Brando, L., Yolken, R. H., Bordón, C., Charman, S. A., Katneni, K., Schultz, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208069109 · Cited by 187
Wang, J.-L., Zhang, N.-Z., Li, T.-T., He, J.-J., Elsheikha, H. M., & Zhu, X.-Q. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.01.005 · Cited by 187
Self-citationAdverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review
Ben-Harari, R. R., Goodwin, E., & Casoy, J. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0206-8 · Cited by 180
McFadden, D. C., Tomavo, S., Berry, E. A., & Boothroyd, J. C. (2000) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(00)00184-5 · Cited by 170
Wilson, E. H., Harris, T. H., Mrass, P., John, B., Tait, E. D., Wu, G. F., Pepper, M., Wherry, E. J., Dzierzinski, F., Roos, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.013 · Cited by 169
Bhadra, R., Gigley, J. P., Weiss, L. M., & Khan, I. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015298108 · Cited by 163
Fuks, J. M., Arrighi, R. B. G., Weidner, J. M., Kumar Mendu, S., Jin, Z., Wallin, R. P. A., Rethi, B., Birnir, B., & Barragan, A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003051 · Cited by 163
Nadipuram, S. M., Kim, E. W., Vashisht, A. A., Lin, A. H., Bell, H. N., Coppens, I., Wohlschlegel, J. A., & Bradley, P. J. (2016) · mBio · doi:10.1128/mbio.00808-16 · Cited by 163
Fischer, H.-G., Bonifas, U., & Reichmann, G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4826 · Cited by 162
Astrocyte gp130 Expression Is Critical for the Control of Toxoplasma Encephalitis
Drögemüller, K., Helmuth, U., Brunn, A., Sakowicz‐Burkiewicz, M., Gutmann, D. H., Müller, W., Deckert, M., & Schlüter, D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2683 · Cited by 158
Schöler, N., Krause, K., Kayser, O., Müller, R. H., Borner, K., Hahn, H. H., & Liesenfeld, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1771-1779.2001 · Cited by 155
The Toxoplasma Parasitophorous Vacuole: An Evolving Host–Parasite Frontier
Clough, B., & Frickel, E. (2017) · Trends in Parasitology · doi:10.1016/j.pt.2017.02.007 · Cited by 152
The Bradyzoite: A Key Developmental Stage for the Persistence and Pathogenesis of Toxoplasmosis
Cerutti, A., Blanchard, N., & Besteiro, S. (2020) · Pathogens · doi:10.3390/pathogens9030234 · Cited by 151
Meneceur, P., Bouldouyre, M., Aubert, D., Villena, I., Ménotti, J., Sauvage, V., Garin, J.-F., & Derouin, F. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01203-07 · Cited by 148
Lüder, C. G. K., Giraldo‐Velásquez, M., Sendtner, M., & Groß, U. (1999) · Experimental Parasitology · doi:10.1006/expr.1999.4421 · Cited by 147
Gamma Interferon-Induced Inhibition ofToxoplasma gondiiin Astrocytes Is Mediated by IGTP
Halonen, S. K., Taylor, G. A., & Weiss, L. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.9.5573-5576.2001 · Cited by 145
Food Attribution and Economic Cost Estimates for Meat- and Poultry-Related Illnesses
Scharff, R. L. (2020) · Journal of Food Protection · doi:10.4315/jfp-19-548 · Cited by 144
Cekanaviciute, E., Dietrich, H. K., Axtell, R. C., Williams, A. M., Egusquiza, R. J., Wai, K. M., Koshy, A. A., & Buckwalter, M. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303284 · Cited by 143
Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011
Mangen, M.-J. J., Bouwknegt, M., Friesema, I. H. M., Haagsma, J. A., Kortbeek, L. M., Tariq, L., Wilson, M., van Pelt, W., & Havelaar, A. H. (2015) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2014.11.022 · Cited by 140
Bissati, K. E., Levigne, P., Lykins, J. D., V, Adlaoui, E. B., Barkat, A., Berraho, A., Laboudi, M., Mansouri, B. E., Ibrahimi, A., Rhajaoui, M., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0164-4 · Cited by 140
Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample
Hamdani, N., Daban, C., Lajnef, M., Richard, J., Delavest, M., Godin, O., Guen, E. L., Vederine, F.-E., Lépine, J., Jamain, S., et al. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.11.034 · Cited by 138
Complex Immune Cell Interplay in the Gamma Interferon Response during Toxoplasma gondii Infection
Sturge, C. R., & Yarovinsky, F. (2014) · Infection and Immunity · doi:10.1128/iai.01722-14 · Cited by 134
Farhat, D. C., Swale, C., Dard, C., Cannella, D., Ortet, P., Barakat, M., Sindikubwabo, F., Belmudes, L., Bock, P. D., Couté, Y., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0674-4 · Cited by 133
Suzuki, Y., Sa, Q., Gehman, M., & Ochiai, E. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002018 · Cited by 132
Removal of Toxoplasma gondii Cysts from the Brain by Perforin-Mediated Activity of CD8+ T Cells
Suzuki, Y., Wang, X., Jortner, B. S., Payne, L. B., Ni, Y., Michie, S. A., Xu, B., Kudo, T., & Perkins, S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090825 · Cited by 131
Yu, F., Sharma, S., Jankovic, D. L., Gurram, R. K., Su, P., Hu, G., Li, R., Rieder, S. A., Zhao, K., Sun, B., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20170155 · Cited by 131
Toxoplasma gondii and Schizophrenia: Linkage Through Astrocyte-Derived Kynurenic Acid?
Schwarcz, R. M., & Hunter, C. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm030 · Cited by 118
Toxoplasmosis: A pathway to neuropsychiatric disorders
Tyebji, S., Seizova, S., Hannan, A. J., & Tonkin, C. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.11.012 · Cited by 117
A one health approach to vaccines against Toxoplasma gondii
Innes, E. A., Hamilton, C. M., Garcia, J. L., Chryssafidis, A. L., & Smith, D. W. (2019) · Food and Waterborne Parasitology · doi:10.1016/j.fawpar.2019.e00053 · Cited by 111
Batista, S. J., Still, K. M., Johanson, D. M., Thompson, J. A., O’Brien, C. A., Lukens, J. R., & Harris, T. H. (2020) · Nature Communications · doi:10.1038/s41467-020-17491-z · Cited by 109
Lüder, C. G. K., Lang, C., Giraldo‐Velásquez, M., Algner, M., Gerdes, J., & Groß, U. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00320-x · Cited by 107
Shaw, M. H., Freeman, G. J., Scott, M. F., Fox, B. A., Bzik, D. J., Belkaid, Y., & Yap, G. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7263 · Cited by 105
Passage of parasites across the blood-brain barrier
Masocha, W., & Kristensson, K. (2012) · Virulence · doi:10.4161/viru.19178 · Cited by 91
In vitro effects of folate inhibitors on Toxoplasma gondii
Derouin, F., & Chastang, C. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.10.1753 · Cited by 90
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii
Safronova, A., Araujo, A. M., Camanzo, E., Moon, T. J., Elliott, M. R., Beiting, D. P., & Yarovinsky, F. (2018) · Nature Immunology · doi:10.1038/s41590-018-0250-8 · Cited by 90
STAT1 Signaling in Astrocytes Is Essential for Control of Infection in the Central Nervous System
Hidano, S., Randall, L. M., Dawson, L. A., Dietrich, H. K., Konradt, C., Klover, P. J., John, B., Harris, T. H., Fang, Q., Turek, B. J., et al. (2016) · mBio · doi:10.1128/mbio.01881-16 · Cited by 87
Toxoplasma gondii effector TgIST blocks type I interferon signaling to promote infection
Matta, S. K., Olias, P., Huang, Z., Wang, Q., Park, E., Yokoyama, W. M., & Sibley, L. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904637116 · Cited by 84
Rozenfeld, C., Martinez, R., Figueiredo, R. T., Bozza, M. T., Lima, F. R. S., Pires, A. L., Silva, P. M., Bonomo, A., Lannes-Vieira, J., De Souza, W., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.2047-2057.2003 · Cited by 82
Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV
Safarpour, H., Çevik, M., Zarean, M., Barac, A. M., Hatam‐Nahavandi, K., Rahimi, M. T., Baghi, H. B., Jafari‐Koshki, T., Pagheh, A. S., Shahrivar, F., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002424 · Cited by 82
Weidner, J. M., Kanatani, S., Hernández-Castañeda, M. A., Fuks, J. M., Réthi, B., Wallin, R. P. A., & Barragán, A. (2013) · Cellular Microbiology · doi:10.1111/cmi.12145 · Cited by 81
Chitinase Dependent Control of Protozoan Cyst Burden in the Brain
Nance, J. P., Vannella, K. M., Worth, D., David, C. N., Carter, D., Noor, S., Hubeau, C., Fitz, L. J., Lane, T. E., Wynn, T. A., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002990 · Cited by 81
Maubon, D., Bougdour, A., Wong, Y., Brenier‐Pinchart, M., Curt, A., Hakimi, M., & Pelloux, H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00462-10 · Cited by 81
Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box
Spalenka, J., Escotte‐Binet, S., Bakiri, A., Hubert, J., Renault, J., Velard, F., Duchateau, S., Aubert, D., Huguenin, A., & Villena, I. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01640-17 · Cited by 81
Ochiai, E., Sa, Q., Brogli, M., Kudo, T., Wang, X., Dubey, J. P., & Suzuki, Y. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.10.003 · Cited by 79
Dittmar, A., Drozda, A. A., & Blader, I. J. (2016) · mSphere · doi:10.1128/msphere.00042-15 · Cited by 79
A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients
Raffi, F., Aboulker, J.-P., Michelet, C., Reliquet, V., Pelloux, H., Huart, A., Poizot‐Martin, I., Morlat, P., Dupas, B., Mussini, J. M., et al. (1997) · AIDS · doi:10.1097/00002030-199702000-00007 · Cited by 78
Schlüter, D., Deckert, M., Hof, H., & Frei, K. (2001) · Infection and Immunity · doi:10.1128/iai.69.12.7889-7893.2001 · Cited by 77
Boyom, F. F., Fokou, P. V. T., Tchokouaha, L. R. Y., Spangenberg, T., Mfopa, A. N., Toghueo, R. M. K., Mbouna, C. D. J., Donfack, V. F. D., & Zollo, P. H. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02541-14 · Cited by 74
Wang, X., Michie, S. A., Xu, B., & Suzuki, Y. (2007) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.0154 · Cited by 71
PD-1–Mediated Attrition of Polyfunctional Memory CD8+ T Cells in Chronic Toxoplasma Infection
Bhadra, R., Gigley, J. P., & Khan, I. A. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis304 · Cited by 71
Shubar, H. M., Lachenmaier, S., Heimesaat, M. M., Lohman, U., Mauludın, R., Mueller, R. H., Fitzner, R., Borner, K., & Liesenfeld, O. (2010) · Journal of drug targeting · doi:10.3109/10611861003733995 · Cited by 71
Protozoa traversal of the blood–brain barrier to invade the central nervous system
Elsheikha, H. M., & Khan, N. A. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00215.x · Cited by 71
Self-citationDerouin, F. (2001) · PubMed · Cited by 69
Rozenfeld, C., Martinez, R., Seabra, S. H., Sant’Anna, C., Gonçalves, J. G. R., Bozza, M. T., Moura‐Neto, V., & de Souza, W. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61191-1 · Cited by 69
Guanabenz Repurposed as an Antiparasitic with Activity against Acute and Latent Toxoplasmosis
Benmerzouga, I., Checkley, L. A., Ferdig, M. T., Arrizabalaga, G., Wek, R. C., & Sullivan, W. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01683-15 · Cited by 66
Drewry, L. L., Jones, N. G., Wang, Q., Onken, M. D., Miller, M. J., & Sibley, L. D. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0504-8 · Cited by 66
Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites
Murata, Y., Sugi, T., Weiss, L. M., & Kato, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178203 · Cited by 63
Benevides, L., Milanezi, C. M., Yamauchi, L. M., Benjamim, C. F., Silva, J. S., & Silva, N. M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080129 · Cited by 62
Clark, R. T., Nance, J. P., Noor, S., & Wilson, E. H. (2011) · ASN NEURO · doi:10.1042/an20100027 · Cited by 62
Kanatani, S., Fuks, J. M., Olafsson, E. B., Westermark, L., Chambers, B. J., Varas‐Godoy, M., Uhlén, P., & Barragán, A. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006739 · Cited by 61
Wen, X., Kudo, T., Payne, L. B., Wang, X., Rodgers, L., & Suzuki, Y. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0119 · Cited by 60
Burden of Disease Estimates of Seven Pathogens Commonly Transmitted Through Foods in Denmark, 2017
Pires, S. M., Jakobsen, L. S., Ellis‐Iversen, J., Pessoa, J., & Ethelberg, S. (2019) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2019.2705 · Cited by 58
Latent Toxoplasmosis Effects on Rodents and Humans: How Much is Real and How Much is Media Hype?
Johnson, H. J., & Koshy, A. A. (2020) · mBio · doi:10.1128/mbio.02164-19 · Cited by 58
The Toxoplasma gondii virulence factor ROP16 acts in cis and trans, and suppresses T cell responses
Chen, L., Christian, D. A., Kochanowsky, J. A., Phan, A. T., Clark, J. T., Wang, S., Berry, C. T., Oh, J. Y., Chen, X., Roos, D. S., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20181757 · Cited by 57
Weidner, J. M., Kanatani, S., Uchtenhagen, H., Varas‐Godoy, M., Schulte, T., Engelberg, K., Gubbels, M., Sun, H., Harrison, R. E., Achour, A., et al. (2016) · Cellular Microbiology · doi:10.1111/cmi.12595 · Cited by 55
Sher, A., Tosh, K. W., & Jankovic, D. L. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.12 · Cited by 55
Sánchez-Zamora, Y. I., Ruiz‐Rosado, J. D. D., Vega, L., Elizondo, G., Estrada-Muñiz, E., Saavedra, R., Juárez, I., & Rodríguez‐Sosa, M. (2010) · BioMed Research International · doi:10.1155/2010/505694 · Cited by 53
Choroid plexus infection in cerebral toxoplasmosis in AIDS patients
Falangola, M. F., & Petito, C. K. (1993) · Neurology · doi:10.1212/wnl.43.10.2035 · Cited by 51
Bando, H., Lee, Y., Sakaguchi, N., Pradipta, A., Su, J., Tanaka, S., Cai, Y., Liu, J., Shen, J., Nishikawa, Y., et al. (2018) · mBio · doi:10.1128/mbio.01738-18 · Cited by 51
The gut mucosal immune response to Toxoplasma gondii
Cohen, S. B., & Denkers, E. (2014) · Parasite Immunology · doi:10.1111/pim.12164 · Cited by 50
Atmaca, H., Kul, O., Karakuş, E., Terzi, O. S., Canpolat, S., & Anteplıoğlu, T. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.049 · Cited by 49
Pearce, B. D., Kruszon‐Moran, D., & Jones, J. L. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0820-5 · Cited by 48
Detection of cytokine mRNA in the brains of mice with toxoplasmic encephalitis
Hunter, C. A., Roberts, C. W., Murray, M., & Alexander, J. K. (1992) · Parasite Immunology · doi:10.1111/j.1365-3024.1992.tb00015.x · Cited by 46
Olafsson, E. B., Ross, E. C., Varas‐Godoy, M., & Barragán, A. (2019) · Journal of Cell Science · doi:10.1242/jcs.225193 · Cited by 46
Ploix, C. C., Noor, S., Crane, J., Masek, K., Carter, W., Lo, D. D., Wilson, E. H., & Carson, M. J. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.09.014 · Cited by 45
Toxoplasmosis Hospitalizations in the United States, 2008, and Trends, 1993-2008
Jones, J. L., & Roberts, J. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir990 · Cited by 44
Bando, H., Sakaguchi, N., Lee, Y., Pradipta, A., Su, J., Tanaka, S., Lai, D., Liu, J., Lun, Z.-R., Nishikawa, Y., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02073 · Cited by 44
Luu, L., Johnston, L. J., Derricott, H., Armstrong, S. D., Randle, N., Hartley, C. S., Duckworth, C. A., Campbell, B. J., Wastling, J. M., & Coombes, J. L. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00300 · Cited by 44
Long-term course and outcome in AIDS patients with cerebral toxoplasmosis
Arendt, G., von Giesen, H. ‐., Hefter, H., Neuen-Jacob, E., Roick, H., & Jablonowski, H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00735.x · Cited by 43
Christian, D. A., Koshy, A. A., Reuter, M. A., Betts, M. R., Boothroyd, J. C., & Hunter, C. A. (2014) · Infection and Immunity · doi:10.1128/iai.01643-14 · Cited by 43
Sa, Q., Ochiai, E., Sengoku, T., Wilson, M. E., Brogli, M., Crutcher, S., Michie, S. A., Xu, B., Payne, L. B., Wang, X., et al. (2014) · Infection and Immunity · doi:10.1128/iai.01494-13 · Cited by 41
Could miltefosine be used as a therapy for toxoplasmosis?
Eissa, M. M., Barakat, A. M., Amer, E. I., & Younis, L. K. (2015) · Experimental Parasitology · doi:10.1016/j.exppara.2015.06.005 · Cited by 40
Alfonso, Y., Fraga, J., Jiménez, N., Fonseca, C., Dorta‐Contreras, A. J., Cox, R., Capó, V. A., Bandera, F., Suárez, O. P., & Ginorio, D. E. (2009) · Experimental Parasitology · doi:10.1016/j.exppara.2009.03.009 · Cited by 40
Anselmo, L. M. P., Vilar, F. C., Lima, J. E., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.08.034 · Cited by 39
da Silva, D. S., Oliveira, B. C. D. L., Resende, T. L., Schuindt, S. H. S., Pimentel, P. M. D. O., Kanashiro, M. M., & Arnholdt, A. C. V. (2010) · Veterinary Parasitology · doi:10.1016/j.vetpar.2009.12.042 · Cited by 37
Deciphering the Draft Genome of Toxoplasma gondii RH Strain
Lau, Y. L., Lee, W.-C., Gudimella, R., Zhang, G., Ching, X. T., Razali, R., Aziz, F. A., Anwar, A., & Fong, M.-Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157901 · Cited by 37
Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain
Landrith, T. A., Harris, T. H., & Wilson, E. H. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0487-3 · Cited by 36
O’Brien, C. A., Overall, C. M., Konradt, C., Hall, A. O., Hayes, N. W., Wagage, S., John, B., Christian, D. A., Hunter, C. A., & Harris, T. H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601581 · Cited by 36
Wang, J.-L., Liang, Q.-L., Li, T.-T., He, J.-J., Bai, M.-J., Cao, X.-Z., Elsheikha, H. M., & Zhu, X.-Q. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900410 · Cited by 35
Self-citationXiao, J., Li, Y., Yolken, R. H., & Viscidi, R. P. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.013 · Cited by 34
Tenorio, E. P., Fernández, J., Castellanos, C., Olguín, J. E., & Saavedra, R. (2011) · European Journal of Immunology · doi:10.1002/eji.201141507 · Cited by 32
Tiwari, A., Hannah, R., Lutshumba, J., Ochiai, E., Weiss, L. M., & Suzuki, Y. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.04.018 · Cited by 32
Levine, A. J., Hinkin, C. H., Ando, K., Santangelo, G., Martínez, M., Valdes‐Sueiras, M., Saxton, E. H., Mathisen, G., Commins, D., Moe, A. A., et al. (2008) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390701819036 · Cited by 29
Toxoplasma gondii infection and schizophrenia: an inter-kingdom communication perspective
Elsheikha, H., & Zhu, X.-Q. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000265 · Cited by 29
Self-citationBharti, A., McCutchan, A., Deutsch, R., Smith, D. M., Ellis, R. J., Cherner, M., Woods, S. P., Heaton, R. K., Grant, I., & Letendre, S. L. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw655 · Cited by 29
Beiting, D. P., Hidano, S., Baggs, J. E., Geskes, J. M., Fang, Q., Wherry, E. J., Hunter, C. A., Roos, D. S., & Cherry, S. R. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002200 · Cited by 28
Life-Threatening Complications of HIV Infection
Davaro, R. E., & Thirumalai, A. (2007) · Journal of Intensive Care Medicine · doi:10.1177/0885066606297964 · Cited by 28
Liang, Q., Sun, L., Elsheikha, H. M., Cao, X., Nie, L.-B., Li, T., Li, T.-S., Zhu, X., & Wang, J. (2020) · Microorganisms · doi:10.3390/microorganisms8030352 · Cited by 28
Self-citationLutshumba, J., Ochiai, E., Sa, Q., Anand, N., & Suzuki, Y. (2020) · mSystems · doi:10.1128/msystems.00189-20 · Cited by 28
Bhandage, A. K., & Barragán, A. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00061 · Cited by 26
Essential Role of mGBP7 for Survival of Toxoplasma gondii Infection
Steffens, N., Beuter-Gunia, C., Kravets, E., Reich, A., Legewie, L., Pfeffer, K., & Degrandi, D. (2020) · mBio · doi:10.1128/mbio.02993-19 · Cited by 26
Toxoplasma gondii Inactivates Human Plasmacytoid Dendritic Cells by Functional Mimicry of IL-10
Pierog, P., Zhao, Y., Singh, S., Dai, J., Yap, G. S., & Fitzgerald-Bocarsly, P. A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701045 · Cited by 20
Li, T., Wang, J., Liang, Q., Sun, L., Zhang, H.-S., Zhang, Z.-W., Zhu, X., & Elsheikha, H. M. (2020) · Parasitology Research · doi:10.1007/s00436-020-06815-z · Cited by 20
Self-citationYoshida, N., Domart, M., Peddie, C. J., Yakimovich, A., Mazón, M. J., Hawkins, T. A., Collinson, L., Mercer, J., Frickel, E., & Mostowy, S. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.043091 · Cited by 19
Cummings, P. L., Kuo, T., Javanbakht, M., & Sorvillo, F. J. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0287 · Cited by 18
Schurer, J. M., Rafferty, E., Schwandt, M., Zeng, W., Farag, M., & Jenkins, E. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0729 · Cited by 17
Wang, M., Zhang, F.-K., Elsheikha, H. M., Zhang, N., He, J.-J., Luo, J., & Zhu, X.-Q. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-3179-8 · Cited by 17
Self-citationBelk, K. W., Connolly, M. P., Schlesinger, L., & Ben-Harari, R. R. (2018) · Pathogens and Global Health · doi:10.1080/20477724.2018.1552644 · Cited by 16
ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain
O’Brien, C. A., & Harris, T. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228251 · Cited by 11
Disease burden of food-related pathogens in the Netherlands, 2016
Mj, M., Friesema, I. H. M., Ja, H., & van Pelt, W. (2017) · Rivm (National Institute for Public Health and the Environment) · doi:10.21945/rivm-2017-0097 · Cited by 10
Harun, M. S. R., Taylor, M., Zhu, X., & Elsheikha, H. M. (2020) · Microorganisms · doi:10.3390/microorganisms8060842 · Cited by 7
Self-citationDisease burden of food-related pathogens in the Netherlands, 2011
Bouwknegt, M., Mangen, M.-J. J., Ihm, F., van Pelt, W., & Havelaar, A. H. (2013) · Rivm Repository (Netherlands National Institute for Public Health and the Environment) · doi:10.21945/rivm-2017-0061 · Cited by 2
Cited by
Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections
Olie, S. E., Andersen, C. Ø., van de Beek, D., & Brouwer, M. C. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-24 · Cited by 38
“Cerebral toxoplasmosis typically presents with contrast-enhancing brain lesions and brain imaging studies are key in the diagnosis (275).”
Protective immunity induced by TgMIC5 and TgMIC16 DNA vaccines against toxoplasmosis
Zhu, Y.-C., Ma, L.-J., Zhang, J.-L., Liu, J.-F., He, Y., Feng, J.-Y., & Chen, J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.686004 · Cited by 16
Metadata
- Authors
- Elsheikha, H. M., Marra, C. M., & Zhu, X.-Q.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2020-12-16
- Volume
- 34
- Issue
- 1
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W3108168291
- Cited by
- 262
- References
- 181
- FWCI
- 16.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.